Clinical Trial Update: Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating influenza vaccination to prevent flu in patients with plasma cell neoplasms has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasma Cell Neoplasm

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Emory University | Conditions: Plasma Cell Neoplasm | Phase 4 | Status: COMPLETED | Results posted: 2025-02-28